Within-subject pharmacokinetic variability has a strong influence on individual exposure ratios in bioequivalence studies, hence on drug formulation interchangeability.
Summary: Introduction: Bioequivalence between a reference and a generic drug is based on the hypothesis that a ± 20% change in blood exposure (or ± 10% for drugs with narrow therapeutic index, NTI) following the generic/reference switch will not have any therapeutic consequences. However, the indivi...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 79; no. 11; pp. 1565 - 1579 |
|---|---|
| Autores principales: | , , , |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Springer Nature
Nov2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |